This inventor holds 3 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1994-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-1996
Title: Innovations by Charles A. Harrington in the Field of Immunoassays
Introduction
Charles A. Harrington, an accomplished inventor based in Lake Villa, IL, has made significant contributions to the field of immunoassay methods. With a total of three patents to his name, Harrington has developed innovative techniques that advance the quantification of tricyclic antidepressants, particularly imipramine and desipramine.
Latest Patents
Harrington's latest patents focus on reagents and methods for the quantification of imipramine and desipramine. These immunoassay methods are designed to specifically measure these compounds in test samples using antibodies prepared from derivatives of imipramine and desipramine. His inventions include unique labeled reagents that utilize fluorescein derivatives for increased detection efficacy. Additionally, he has developed methods that enable the determination of tricyclic antidepressants in the presence of interfering compounds, ensuring reliable analytical outcomes through immunoassay techniques, high-pressure liquid chromatography, and thin-layer chromatography.
Career Highlights
Harrington has built a notable career at Abbott Laboratories Corporation, contributing to pharmaceutical advancements through his innovative methods. His work not only enhances the accuracy of drug testing but also promotes better patient outcomes in the field of mental health.
Collaborations
Throughout his career, Harrington has collaborated with esteemed coworkers like Maciej B. Adamczyk and Donald D. Johnson. These collaborations have fostered an environment of creativity and innovation, leading to the successful development of his patented technologies.
Conclusion
Charles A. Harrington exemplifies the spirit of innovation in the pharmaceutical industry. His patents provide invaluable methods for accurately quantifying important psychiatric medications, showcasing how committed inventors can lead to advancements that significantly impact healthcare. Through his work, Harrington has set a benchmark for future researchers and inventors in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile